MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
Paving the Way for European Clinical Entry and Global Technology Transfer A Milestone Partnership Highlighting…
Paving the Way for European Clinical Entry and Global Technology Transfer A Milestone Partnership Highlighting…
SEOUL, South Korea--(BUSINESS WIRE)--ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced…
MARLBOROUGH, Mass.--(BUSINESS WIRE)--#AI--SCIEX, a global leader in life science analytical technologies and operating company of…
- Clinically meaningful anti-tumor activity of ZL-1310 observed in heavily pretreated population of patients with…
SYDNEY--(BUSINESS WIRE)--James Hardie Industries plc (ASX: JHX) (“James Hardie†or the “Companyâ€) announced today that…
PLEASANTON, Calif.--(BUSINESS WIRE)--AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, announced…
Daiichi Sankyo and AstraZeneca’s ENHERTU plus pertuzumab showed a median progression-free survival greater than three…
NEW YORK & NOIDA, India--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today…
MARLBOROUGH, Mass.--(BUSINESS WIRE)--#ZenoTOF--At ASMS 2025, SCIEX, a global leader in life science analytical technologies and…
LIMOGES, France--(BUSINESS WIRE)--Regulatory News: Legrand (Paris:LR) is pursuing its active bolt-on acquisition strategy with today’s…